FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 336:1569-1574 May 29, 1997 Number 22 Next

	Full Text PDF Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Despite decades of basic and clinical research and trials of promising new therapies, cancer remains a major cause of morbidity and mortality. We assessed overall progress against cancer in the United States from 1970 through 1994 by analyzing changes in age-adjusted mortality rates.

Methods We obtained from the National Center for Health Statistics data on all deaths from cancer and from cancer at specific sites, as well as on deaths due to cancer according to age, race, and sex, for the years 1970 through 1994. We computed age-specific mortality rates and adjusted them to the age distribution of the U.S. population in 1990.

Results Age-adjusted mortality due to cancer in 1994 (200.9 per 100,000 population) was 6.0 percent higher than the rate in 1970 (189.6 per 100,000). After decades of steady increases, the age-adjusted mortality due to all malignant neoplasms plateaued, then decreased by 1.0 percent from 1991 to 1994. The decline in mortality due to cancer was greatest among black males and among persons under 55 years of age. Mortality among white males 55 or older has also declined recently. These trends reflect a combination of changes in death rates from specific types of cancer, with important declines due to reduced cigarette smoking and improved screening and a mixture of increases and decreases in the incidence of types of cancer not closely related to tobacco use.

Conclusions The war against cancer is far from over. Observed changes in mortality due to cancer primarily reflect changing incidence or early detection. The effect of new treatments for cancer on mortality has been largely disappointing. The most promising approach to the control of cancer is a national commitment to prevention, with a concomitant rebalancing of the focus and funding of research.

Source Information

Presented in part as the Ramazzini Lecture, given by Dr. Bailar on October 26, 1996, in Carpi, Italy, as part of the annual Ramazzini Days of the Collegium Ramazzini.

From the Department of Health Studies, University of Chicago, 5841 S. Maryland Ave., MC 2007, Chicago, IL 60637-1470, where reprint requests should be addressed to Dr. Bailar.

Full Text of this Article

Related Letters:

Winning the War on Cancer
Mayer R. J., Schnipper L. E., Broder S., Hughes-Davies T.H., Rand T. S., Cole P., Rodu B., Corey S., Suit H., Isselbacher K., Chabner B., Feldman A., Atkins R. N., Arlen P. A., Noxon C. L., Wilcken N., Bailar J. C., Gornik H. L.
Extract | Full Text  
N Engl J Med 1997; 337:935-938, Sep 25, 1997. Correspondence

This article has been cited by other articles:

• Kort, E. J., Paneth, N., Vande Woude, G. F. (2009). The Decline in U.S. Cancer Mortality in People Born since 1925. Cancer Res. 69: 6500-6505 [Abstract] [Full Text]  
• Manton, K. G., Gu, X.-L., Lowrimore, G., Ullian, A., Tolley, H. D. (2009). NIH funding trajectories and their correlations with US health dynamics from 1950 to 2004. Proc. Natl. Acad. Sci. USA 106: 10981-10986 [Abstract] [Full Text]  
• Frieden, T. R., Myers, J. E., Krauskopf, M. S., Farley, T. A. (2008). A Public Health Approach to Winning the War Against Cancer. The Oncologist 13: 1306-1313 [Abstract] [Full Text]  
• Parmar, M. K. B., Barthel, Friederike. M.-S., Sydes, M., Langley, R., Kaplan, R., Eisenhauer, E., Brady, M., James, N., Bookman, M. A., Swart, A.-M., Qian, W., Royston, P. (2008). Speeding up the Evaluation of New Agents in Cancer. JNCI J Natl Cancer Inst 100: 1204-1214 [Abstract] [Full Text]  
• Kopetz, S., Overman, M., Chang, D. Z., Glover, K. Y., Shureiqi, I., Wolff, R. A., Abbruzzese, J. L., Eng, C. (2008). Systematic Survey of Therapeutic Trials for Metastatic Colorectal Cancer: Room for Improvement in the Critical Pathway. JCO 26: 2000-2005 [Abstract] [Full Text]  
• Royston, P., Parmar, M. K. B., Altman, D. G. (2008). Visualizing Length of Survival in Time-to-Event Studies: A Complement to Kaplan Meier Plots. JNCI J Natl Cancer Inst 100: 92-97 [Abstract] [Full Text]  
• Blansfield, J. A., Caragacianu, D., Alexander, H. R. III, Tangrea, M. A., Morita, S. Y., Lorang, D., Schafer, P., Muller, G., Stirling, D., Royal, R. E., Libutti, S. K. (2008). Combining Agents that Target the Tumor Microenvironment Improves the Efficacy of Anticancer Therapy. Clin. Cancer Res. 14: 270-280 [Abstract] [Full Text]  
• Klenk, J., Rapp, K., Buchele, G., Keil, U., Weiland, S. K. (2007). Increasing life expectancy in Germany: quantitative contributions from changes in age- and disease-specific mortality. Eur J Public Health 17: 587-592 [Abstract] [Full Text]  
• Amino, N., Ideyama, Y., Yamano, M., Kuromitsu, S., Tajinda, K., Samizu, K., Hisamichi, H., Matsuhisa, A., Shirasuna, K., Kudoh, M., Shibasaki, M. (2006). YM-359445, an Orally Bioavailable Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor, Has Highly Potent Antitumor Activity against Established Tumors. Clin. Cancer Res. 12: 1630-1638 [Abstract] [Full Text]  
• Jatoi, I., Anderson, W. F., Rao, S. R., Devesa, S. S. (2005). Breast Cancer Trends Among Black and White Women in the United States. JCO 23: 7836-7841 [Abstract] [Full Text]  
• Kravitz, R. L. (2005). Doing Things Better vs Doing Better Things. Ann Fam Med 3: 483-485 [Full Text]  
• Erker, L., Schubert, R., Yakushiji, H., Barlow, C., Larson, D., Mitchell, J. B., Wynshaw-Boris, A. (2005). Cancer chemoprevention by the antioxidant tempol acts partially via the p53 tumor suppressor. Hum Mol Genet 14: 1699-1708 [Abstract] [Full Text]  
• Harrington, K. F., Franklin, F. A., Davies, S. L., Shewchuk, R. M., Binns, M. B. (2005). Implementation of a Family Intervention to Increase Fruit and Vegetable Intake: The Hi5+ Experience. Health Promot Pract 6: 180-189 [Abstract]  
• Chang, X., Tou, J. C., Hong, C., Kim, H.-A., Riby, J. E., Firestone, G. L., Bjeldanes, L. F. (2005). 3,3'-Diindolylmethane inhibits angiogenesis and the growth of transplantable human breast carcinoma in athymic mice. Carcinogenesis 26: 771-778 [Abstract] [Full Text]  
• Paolini, M., Perocco, P., Canistro, D., Valgimigli, L., Pedulli, G. F., Iori, R., Croce, C. D., Cantelli-Forti, G., Legator, M. S., Abdel-Rahman, S. Z. (2004). Induction of cytochrome P450, generation of oxidative stress and in vitro cell-transforming and DNA-damaging activities by glucoraphanin, the bioprecursor of the chemopreventive agent sulforaphane found in broccoli. Carcinogenesis 25: 61-67 [Abstract] [Full Text]  
• Roberts, T. G. Jr, Lynch, T. J. Jr, Chabner, B. A. (2003). The Phase III Trial in the Era of Targeted Therapy: Unraveling the "Go or No Go" Decision. JCO 21: 3683-3695 [Abstract] [Full Text]  
• Nair, S., Boczkowski, D., Moeller, B., Dewhirst, M., Vieweg, J., Gilboa, E. (2003). Synergy between tumor immunotherapy and antiangiogenic therapy. Blood 102: 964-971 [Abstract] [Full Text]  
• Garattini, S. (2003). New approaches to cancer therapy. Ann Oncol 14: 813-816 [Full Text]  
• Lippman, S. M., Hong, W. K. (2002). Cancer Prevention Science and Practice. Cancer Res. 62: 5119-5125 [Full Text]  
• Anderson, W. F., Guyton, K. Z., Hiatt, R. A., Vernon, S. W., Levin, B., Hawk, E. (2002). Colorectal Cancer Screening for Persons at Average Risk. JNCI J Natl Cancer Inst 94: 1126-1133 [Full Text]  
• Garattini, S., Bertele', V. (2002). Efficacy, safety, and cost of new anticancer drugs. BMJ 325: 269-271 [Full Text]  
• Andersen, L. D., Remington, P., Trentham-Dietz, A., Reeves, M. (2002). Assessing a Decade of Progress in Cancer Control. The Oncologist 7: 200-204 [Abstract] [Full Text]  
• Temple, N. J., Balay-Karperien, A. L. (2002). Nutrition in Cancer Prevention: An Integrated Approach. J. Am. Coll. Nutr. 21: 79-83 [Abstract] [Full Text]  
• TOMATIS, L., MELNICK, R. L., HASEMAN, J., BARRETT, J. C., HUFF, J. (2001). Alleged misconceptions' distort perceptions of environmental cancer risks. FASEB J. 15: 195-203 [Abstract] [Full Text]  
• Stockmeyer, B., Dechant, M., van Egmond, M., Tutt, A. L., Sundarapandiyan, K., Graziano, R. F., Repp, R., Kalden, J. R., Gramatzki, M., Glennie, M. J., van de Winkel, J. G. J., Valerius, T. (2000). Triggering FC{alpha}-Receptor I (CD89) Recruits Neutrophils as Effector Cells for CD20-Directed Antibody Therapy. J. Immunol. 165: 5954-5961 [Abstract] [Full Text]  
• Richardson, M. A., Sanders, T., Palmer, J. L., Greisinger, A., Singletary, S. E. (2000). Complementary/Alternative Medicine Use in a Comprehensive Cancer Center and the Implications for Oncology. JCO 18: 2505-2514 [Abstract] [Full Text]  
• Browder, T., Butterfield, C. E., Kräling, B. M., Shi, B., Marshall, B., O’Reilly, M. S., Folkman, J. (2000). Antiangiogenic Scheduling of Chemotherapy Improves Efficacy against Experimental Drug-resistant Cancer. Cancer Res. 60: 1878-1886 [Abstract] [Full Text]  
• Walker, A.R.P., Walker, B.F., Jerling, J., Rossouw, K., Lelake, A. (1999). Health and cancer prevention: implications of the knowledge and beliefs of 15-16 year old school pupils in South Africa. The Journal of the Royal Society for the Promotion of Health 119: 80-84 [Abstract]  
• Hayes, A J, Li, L Y, Lippman, M E (1999). Science, medicine, and the future: Antivascular therapy: a new approach to cancer treatment. BMJ 318: 853-856 [Full Text]  
• Zheng, Y., Kramer, P. M., Lubet, R. A., Steele, V. E., Kelloff, G. J., Pereira, M. A. (1999). Effect of retinoids on AOM-induced colon cancer in rats: modulation of cell proliferation, apoptosis and aberrant crypt foci. Carcinogenesis 20: 255-260 [Abstract] [Full Text]  
• Li, F. P. (1999). Cancer Control in Susceptible Groups: Opportunities and Challenges. JCO 17: 719-719 [Abstract] [Full Text]  
• Manton, K. G., Stallard, E. (1998). Forecasting Methods for HIV/AIDS and Aging. Research on Aging 20: 846-864 [Abstract]  
• Linggood, R., Govern, F., Coleman, C. N. (1998). A Blueprint for Linking Academic Oncology and the Community. Journal of Health Politics, Policy and Law 23: 973-994 [Abstract]  
• Li, R., Yerganian, G., Duesberg, P., Kraemer, A., Willer, A., Rausch, C., Hehlmann, R. (1997). Aneuploidy correlated 100% with chemical transformation of Chinese hamster cells. Proc. Natl. Acad. Sci. USA 94: 14506-14511 [Abstract] [Full Text]  
• Nestle, M. (1997). Broccoli sprouts as inducers of carcinogen-detoxifying enzyme systems: Clinical, dietary, and policy implications. Proc. Natl. Acad. Sci. USA 94: 11149-11151 [Full Text]  
• Kramer, B. S., Klausner, R. D. (1997). Grappling with Cancer -- Defeatism versus the Reality of Progress. NEJM 337: 931-935 [Full Text]  
• Mayer, R. J., Schnipper, L. E., Broder, S., Hughes-Davies, T.H., Rand, T. S., Cole, P., Rodu, B., Corey, S., Suit, H., Isselbacher, K., Chabner, B., Feldman, A., Atkins, R. N., Arlen, P. A., Noxon, C. L., Wilcken, N., Bailar, J. C., Gornik, H. L. (1997). Winning the War on Cancer. NEJM 337: 935-938 [Full Text]